Melissa Angelini
Investor Relations Contact at PROCAPS GROUP S.A.
Profile
Melissa Angelini is currently the Director-Investor Relations at Procaps Group SA since 2022.
Prior to this, she worked as the Head-Investor Relations at Blau Farmacêutica SA and as the Manager-Investor Relations at Biotoscana Investments SA from 2017 to 2019.
Ms. Angelini completed her undergraduate degree at Universidad de Palermo and her MBA at Insper Institute of Education & Research.
Melissa Angelini active positions
| Companies | Position | Start |
|---|---|---|
| PROCAPS GROUP S.A. | Investor Relations Contact | 2022-01-31 |
Former positions of Melissa Angelini
| Companies | Position | End |
|---|---|---|
| BLAU FARMACÊUTICA S.A. | Public Communications Contact | - |
| BIOTOSCANA INVESTMENTS S.A. | Investor Relations Contact | - |
Training of Melissa Angelini
| Universidad de Palermo | Undergraduate Degree |
| Insper Institute of Education & Research | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BLAU FARMACÊUTICA S.A. | Health Technology |
| PROCAPS GROUP S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Biotoscana Investments SA
 Biotoscana Investments SA Pharmaceuticals: MajorHealth Technology Biotoscana Investments SA operates as a holding company, which engages in the development, manufacturing and commercialization of advanced medicine. Its operations include oncology, onco-hematology, severe infectious diseases, genetic and rare conditions as well as immunology and inflammation. The company was founded in August 16, 2011 and is headquartered in Montevideo, Uruguay. | Health Technology |
- Stock Market
- Insiders
- Melissa Angelini